Oncology and Hematology
Episodes 81-96 of 116
- MinuteCE®
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
0.75 program creditsAdam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Adam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Christopher M. Gallagher, MD
Adam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Ticiana Leal, MD
Jacob Sands, MD
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
- MinuteCE®
Case Study: Sequencing Therapy in ES-SCLC in Special Patient Populations
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
Jessica S. Donington, MD, MSCR
Joshua E. Reuss, MD
- MinuteCE®
Case Study: Treatment Sequencing in Platinum-Resistant Relapse ES-SCLC
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
Ticiana Leal, MD
Jacob Sands, MD
- MinuteCE®
Panel Discussion: Patient Selection, Emerging Studies and Strategies in ES-SCLC
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
- MinuteCE®
Case Study: Treatment Sequencing in Platinum-Sensitive Relapse ES-SCLC
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
- MinuteCE®
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
1.00 program creditKelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH